US2022257272A1PendingUtilityA1
Methods and devices to treat nasal airways
Est. expiryJun 14, 2031(~4.9 yrs left)· nominal 20-yr term from priority
A61N 5/0603A61B 2018/00922A61B 2018/00928A61B 2018/0022A61B 18/20A61F 5/08A61B 18/1445A61M 2025/105A61F 7/10A61N 5/0625A61B 18/14A61B 2018/126A61B 17/320068A61B 2018/00327A61N 1/403A61N 7/022A61B 2018/00023A61B 18/02A61B 18/1206A61B 17/24A61B 2018/0262A61B 18/06A61N 5/025A61B 2018/00994A61B 2018/0212A61B 18/1815A61B 2018/00982A61B 2018/0091A61B 2018/1253A61B 18/1485A61B 2017/248A61B 2018/00821A61B 2018/00708A61B 2018/1861A61B 2018/00791A61B 2018/0225A61B 2018/00434A61B 2018/00702A61B 2018/00875A61B 2018/1425A61B 2018/044A61B 2018/1467A61B 2018/00178A61B 2018/00595A61B 2018/00005A61B 2018/0016A61B 2018/00577A61B 18/1477A61B 18/085A61B 2018/1807A61B 2018/143A61F 5/56A61B 2018/00886F04C 2270/041A61B 2018/00642A61B 17/2816A61B 5/01A61B 18/16A61B 18/1442A61B 18/12
69
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
A method for reshaping a nasal airway in a patient involves advancing an inflatable balloon of a reshaping device in an uninflated configuration into a nostril of the patient and between a nasal septum and a lateral wall of the nasal airway. The method then involves inflating the inflatable balloon to an inflated configuration to cause the inflatable balloon to contact nasal mucosa covering the nasal septum and the lateral wall, delivering energy from an energy delivery member attached to or inside of the inflatable balloon, and removing the reshaping device from the nasal airway.
Claims
exact text as granted — not AI-modifiedWhat is claimed is:
1 . A method for treating rhinitis in a patient, without forming an incision or leaving behind an implant, the method comprising:
advancing a treatment element of a nasal airway treatment device through a nostril of the patient and into a nasal airway, wherein the treatment element comprises:
a balloon; and
multiple bipolar radiofrequency electrodes coupled with the balloon;
inflating the balloon to contact the bipolar radiofrequency electrodes with nasal mucosa lining the nasal airway; delivering radiofrequency energy with the bipolar radiofrequency electrodes to nerve tissue underlying the nasal mucosa, to ablate the nerve tissue; deflating the balloon; and removing the nasal airway treatment device from the nasal airway, without leaving any of the implant behind in the nasal airway, wherein ablating the nerve tissue reduces one or more symptoms of rhinitis.
2 . The method of claim 1 , wherein inflating the balloon applies sufficient force to a nasal turbinate in the nasal airway to deform and break bone in the nasal turbinate.
3 . The method of claim 1 , wherein the bipolar radiofrequency electrodes are attached to an outer surface of the balloon.
4 . The method of claim 3 , wherein the bipolar radiofrequency electrodes comprise multiple linear bipolar electrode pairs that expand when the balloon expands.
5 . The method of claim 3 , wherein the bipolar radiofrequency electrodes are coupled with a wire mesh substrate.
6 . The method of claim 1 , wherein the nerve tissue is part of at least one nerve selected from the group consisting of a posterior nasal nerve, an ethmoidal nerve, and a sphenopalatine ganglion.
7 . The method of claim 1 , further comprising determining that the patient suffers from poor nasal airflow, wherein the method improves the poor nasal airflow or a perception of the poor nasal airflow.
8 . A method for improving nasal airflow or perceived nasal airflow through a nasal airway in a patient, without forming an incision or leaving behind an implant, the method comprising:
advancing a treatment element of a nasal airway treatment device through a nostril of the patient and into the nasal airway, wherein the treatment element comprises:
a balloon; and
multiple bipolar radiofrequency electrodes coupled with the balloon;
inflating the balloon to contact the bipolar radiofrequency electrodes with nasal mucosa lining the nasal airway; delivering radiofrequency energy with the bipolar radiofrequency electrodes to nerve tissue underlying the nasal mucosa, to ablate the nerve tissue; deflating the balloon; and removing the nasal airway treatment device from the nasal airway, without leaving any of the implant behind in the nasal airway, wherein ablating the nerve tissue improves the nasal airflow or the perceived nasal airflow through the nasal airway.
9 . The method of claim 8 , wherein delivering the radiofrequency energy changes a property of an additional tissue underlying the nasal mucosa, and wherein the property is selected from the group consisting of size, shape, and stiffness.
10 . The method of claim 9 , wherein the property comprises the shape, and wherein the method reshapes the additional tissue to a concave shape.
11 . The method of claim 9 , wherein the property comprises the stiffness, and wherein the method stiffens the additional tissue.
12 . The method of claim 9 , wherein the additional tissue is selected from the group consisting of cartilage and submucosal tissue.
13 . The method of claim 8 , further comprising determining that the patient suffers from chronic or allergic rhinitis, wherein the method ameliorates the chronic or allergic rhinitis.Join the waitlist — get patent alerts
Track US2022257272A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.